Sven Ante Lundberg
CIK 1682126 · President, CEO & PEO · last filed 2026-07-21
Sven Ante Lundberg is a President, CEO & PEO who has filed 34 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for QTTB, was dated Jul 21, 2026. Across all open-market trades the lifetime net is +$466.5K, making them a net buyer over the disclosed history. 1 Form 144 notice of planned sales is also on file; the latest, for VOR on Aug 4, 2025, lists the filer as a director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MRUS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTTB | Director | — | $8.48 | — | $0 | 7 | 2026-07-21 |
| Merus N.V. (MRUS) Delisted | President, CEO & PEO | 0 | $90.00 | $0 | $460.9K | 20 | 2025-12-12 |
| VOR | Director | — | $18.36 | — | $0 | 5 | 2025-05-23 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Scientific Officer | 1,010,834 | — | — | $5.6K | 1 | 2017-02-10 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| MRUS | Direct | 0 | — | 2025-11-28 |
| Madeleine Lundberg 2018 Irrevocable Trust | 0 | — | 2025-12-12 | |
| Ante S Lundberg Qualified Annuity Interest Trust XI | 0 | — | 2025-12-12 | |
| Ante S Lundberg Qualified Annuity Int Trust X | 0 | — | 2025-12-12 | |
| Emily Lundberg 2018 Irrevocable Trust | 0 | — | 2025-12-12 | |
| Kristian Ante Lundberg 2018 Irrevocable Trust | 0 | — | 2025-12-12 | |
| Katrina Lundberg 2018 Irrevocable Trust | 0 | — | 2025-12-12 | |
| Total | 0 | |||
| No longer reported | ||||
| Ante Sven Lundberg Qualified Annuity Interest Trust VI | 0 | — | last 2025-11-28 | |
| Ante S Lundberg Qualified Annuity Int Trust VII | 0 | — | last 2025-11-28 | |
| Ante Sven Lundberg Qualified Annuity Interest Trust IX | 0 | — | last 2025-11-28 | |
| Ante Sven Lundberg Qualified Annuity Interest Trust VIII | 0 | — | last 2025-11-28 | |
| Ante Sven Lundberg Qualified Annuity Interest Trust II | 28,246 | — | last 2022-11-03 | |
| Ante Sven Lundberg Qualified Annuity Interest Trust III | 9,249 | — | last 2022-11-03 | |
| Ante Sven Lundberg Qualified Annuity Interest Trust IV | 74,000 | — | last 2021-03-29 | |
| PZRX | Direct | 505,217 | 50.0% | 2017-02-10 |
| By wife | 505,617 | 50.0% | 2017-02-10 | |
| Total | 1,010,834 | |||
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-21 | QTTB | Grant (A) | — | $0 | EDGAR |
| 2026-06-16 | QTTB | Grant (A) | — | $0 | EDGAR |
| 2026-01-30 | QTTB | Grant (A) | — | $0 | EDGAR |
| 2025-12-12 | Merus N.V. (MRUS) Delisted | Mixed | −83,435 | -$8.09M | EDGAR |
| 2025-11-28 | Merus N.V. (MRUS) Delisted | Gift (G) | −115,305 | $0 | EDGAR |
| 2025-10-27 | QTTB | Grant (A) | — | $0 | EDGAR |
| 2025-08-04 | VOR | Notice (144) Director · Planned Aug 4, 2025 No sale on file |
−29,432 | -$61.6K | EDGAR |
| 2025-05-23 | VOR | Grant (A) | — | $0 | EDGAR |
| 2025-04-21 | Merus N.V. (MRUS) Delisted | Exer (M) | +30,297 | $405.9K | EDGAR |
| 2025-02-26 | QTTB | Mixed | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).